Development of [ 201Tl](III)-DTPA-human polyclonal antibody complex for inflammation detection

Radiochimica Acta

Volumn 95, Issue 11, 2007, Pages 669-675

  Jalilian, A R ^a   Khorrami, A ^b   Tavakoli, M B ^b   Kamali Dehghan, M ^a   Kamrani, Y Y ^a  

^a Nuclear Research Center for Agriculture and Medicine   (Iran)

^b UNIVERSITY OF ISFAHAN   (Iran)

Author keywords

201Tl(III) complex; Biodistribution; Human polyclonal antibody; Inflammation

Indexed keywords

EID: 36349009308     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2007.95.11.669     Document Type: Article

References (22)

1. Jalilian, A. R., Bineshmarvasti, M., Sardari S.: Application of radioisotopes in inflammation. Curr. Med. Chem. 13, 959 (2006).
2. Nijhof, M. W., Oyen, W. J., van Kampen, A., Claessens, R. A., van der Meer, J. W., Corstens, F. H.: Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy. J. Nucl. Med. 38, 1300 (1997).
3. Buscombe, J. R., Oyen, W. J., Grant, A., Claessens, R. A., van der Meer, J., Corstens, F. H., Ell, P. J., Miller, R. F.: Indium-111-labeled polyclonal human immunoglobulin: identifying focal infection in patients positive for human immunodeficiency virus. J. Nucl. Med. 34, 1621 (1993).
4. Oyen, W. J., Claessens, R. A., Raemaekers, J. M., de Pauw, B. E., van der Meer, J. W., Corstens, F. H.: Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G. J. Clin. Oncol. 10, 61 (1992).
5. 99mTc-HMPAO labelled leucocytes in inflammatory bowel disease. Eur. J. Nucl. Med. 22, 664 (1995).
6. 201Tl(III) DPTA-neurotensin (8-13). J. Labelled Compd. Radiopharm. 43, 1227 (2000).
7. 201Tl](III)-Bleomycin for tumor imaging. Radiochimica Acta 94, 453 (2006).
8. 111In-DTPA-human polyclonal antibody complex for long-term inflammation/infection detection. Nukleonika 50, 91 (2005).
9. Eckelman, W. C., Karesh, S. M., Reba, R. C.: New compounds: fatty acid and long chain hydrocarbon derivatives containing a strong chelating agent. J. Pharm. Sci. 64, 704 (1975).
10. Hnatowich, D. J., Layne, W. W., Childs, R. L., Lanteigne, D., Davis, M. A., Griffin, T. W., Doherty, P. W.: Radioactive labeling of antibody: a simple and efficient method. Science 220, 613 (1983).
11. 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors. Bioconjug. Chem. 10, 502 (1999).
12. 177Lu-DOTA-lanreotide: A novel tracer as a targeted agent for tumor therapy. Nucl. Med. Biol. 31, 753 (2004).
13. 225Ac radioimmunopharmaceuticals. Appl. Radiat. Isotopes 57, 841 (2002).
14. 90Y-DOTA for potential application in intra-vascular radionuclide therapy Applied Radiat. Isotopes 57, 313 (2002).
15. 68Ga-DOTATOC: preliminary data. Eur. J. Nucl. Med. 28, 1751 (2001).
16. Laemmli, U. K.: Cleavage of structural proteins during assembly of the head of the bacteriophage T4. Nature 227, 680 (1970).
17. Lan, C. H., Lin, T. S.: Acute toxicity of trivalent thallium compounds to Daphnia magna. Ecotoxicol. Environ. Saf. 61, 432 (2005).
18. Hanzel, C. E., Villaverde, M. S., Verstraeten, S. V.: Glutathione metabolism is impaired in vitro by thallium(III) hydroxide. Toxicology 207, 501 (2005).
19. Villaverde, M. S., Verstraeten, S. V.: Effects of thallium(I) and thallium(III) on liposome membrane physical properties. Arch. Biochem. Biophys. 417, 235 (2003).
20. Coetzee, P. P., Fischer, J. L., Hu, M.: Simultaneous separation and determination of Tl(I) and Tl(III) by IC-ICP-OES and IC-ICP-MS, Water SA Vol. 29 No. 1 January (2003), pp. 17-22.
21. Inczed, Y. J.: Analytical Applications of Complex Equilibria. UK (1976).
22. Tsopelas, C., Penglis, S., Ruskiewicz, A., Bartholomeusz, D. L.: Scintigraphic imaging of experimental colitis with technetium-99m-infliximab in the rat. Hell. J. Nucl. Med. 9, 85 (2006).